Oncology firm posts 33% revenue increase

FORT MYERS — Revenues at 21st Century Oncology Holdings rose 33% to $269.5 million in the fourth quarter compared with the same quarter one year ago.

Meanwhile, the operator of 180 cancer-treatment centers posted a quarterly net loss of $22.7 million in the fourth quarter ending Dec. 31 compared with a net loss of $14.3 million in the same quarter one year ago as expenses rose.

“During 2014, we added a net of 123 new physicians,” says Daniel Dosoretz, the founder and CEO of 21st Century Oncology, in a statement. “Also during the year we added a net of 17 additional centers, 14 of which are domestic and 3 international. We entered 2015 with the same focus on executing our strategy of organic growth combined with prudently taking advantage of attractive strategic de-leveraging acquisitions and joint ventures in order to continue delivering integrated cancer care at academic quality and create compelling value for our steadily expanding patient population.”

For example, in early January the company announced a joint venture with Northwest Cancer Clinic, expanding its geographical reach into a new region in the Northwestern U.S., one of the fastest growing regions in the country.

“I am very pleased with our operational results, both domestic and international, during the fourth quarter,” Dosoretz says. “Early indications in 2015 show continued organic momentum.”

As of Dec. 31, the Fort Myers-based company operated 180 treatment centers, including 144 centers located in 16 states and 36 centers in six countries in Latin America.